PLYX logo

Polaryx Therapeutics, Inc. Common Stock

PLYX
Healthcare|Biotechnology|US
$1.80
+0.06 (+3.45%)
DCF Value
$0.10
Tangible Book / Share
$0.23
Cash / Share
$0.24
Next Earnings Report
Nov 12, 2026
EPS est. -$0.06
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Feb 2, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
Sep 1, 2026 · GlobeNewsWire
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
Aug 25, 2026 · GlobeNewsWire

SEC Filings (26)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 1, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Jul 28, 2026ARSAnnual report to holdersDocumentIndex
Jul 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jul 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 24, 2026S-8Employee stock planDocumentIndex
Jul 21, 20268-KMaterial eventDocumentIndex
Jul 17, 20268-KMaterial eventDocumentIndex
May 28, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
Mar 24, 202610-KAnnual reportDocumentIndex
Feb 5, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Feb 2, 2026424B4Offering prospectusDocumentIndex
Jan 29, 2026EFFECTDocumentIndex
Jan 28, 2026CERTDocumentIndex
Jan 27, 20268-A12BDocumentIndex
Jan 27, 2026S-1/AIPO / offering registrationDocumentIndex
Jan 14, 2026S-1/AIPO / offering registrationDocumentIndex
Nov 21, 2025S-1IPO / offering registrationDocumentIndex
Oct 31, 2025C-UDocumentIndex
Oct 27, 2025C-UDocumentIndex
Oct 1, 2025C/ADocumentIndex
Sep 19, 2025DRS/ADocumentIndex
Sep 3, 2025CDocumentIndex
Aug 5, 2025DRSDocumentIndex